ΑΡΧΙΚΗ
Η ΕΤΑΙΡΕΙΑ
ΘΕΜΑΤΑ ΜΕΛΩΝ
ΕΠΙΣΤΗΜΟΝΙΚΑ ΘΕΜΑΤΑ
ΕΚΠΑΙΔΕΥΣΗ
ΠΕΡΙΟΔΙΚΟ "ΕΛΛΗΝΙΚΗ ΝΕΦΡΟΛOΓΙΑ"
ΟΜΑΔΕΣ ΕΡΓΑΣΙΑΣ
ΚΟΙΝΩΝΙΚΑ ΘΕΜΑΤΑ
ΕΠΑΓΓΕΛΜΑΤΙΕΣ ΥΓΕΙΑΣ
ΝΕΑ
Εισαγωγή
Remember me on this computer
Forgot your password?
Home
Βρίσκεστε εδώ : Βιβλιογραφία
COVID-19 vaccines and kidney disease
COVID-19- associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup (NATURE REVIEWS | NEPHROLOGY, CONSENSUS Statement, volume 16 | December 2020)
Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19 (Clinica Chimica Acta 509 (2020) 220–223, doi.org: 10.1016/j.cca.2020.06.026)
Perspective Piece All together to Fight COVID-19 (Am. J. Trop. Med. Hyg., 102(6), 2020, pp. 1181–1183, doi:10.4269/ajtmh.20-0281)
Comparison of Demand for Drugs Used for COVID-19 Treatment and Other Drugs During the Early Phase of the COVID-19 Pandemic in Italy (JAMA Network Open. 2021;4(2):e2037060. doi:10.1001/jamanetworkopen.2020.37060)
COVID-19 and the Kidney Community: Coalescing in Crisis (Adv Chronic Kidney Dis. 2020;27(5):362-364, doi: 10.1053/j.ackd.2020.10.001)
Experts Discuss COVID-19—Vaccine Doses, Virus Variants, and More (JAMA Published online February 10, 2021)
Researchers Investigate What COVID-19 Does to the Heart (JAMA Published online February 10, 2021)
COVID-19 Vaccination in Pregnant and Lactating Women (JAMA Published online February 8, 2021)
Effectiveness of MaskWearing to Control Community Spread of SARS-CoV-2 (JAMA Published online February 10, 2021)
Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection (JAMA Published online January 26, 2021)
Necessity of 2 Doses of the Pfizer andModerna COVID-19 Vaccines (JAMA Published online February 3, 2021)
Monoclonal Antibodies for COVID-19 (JAMA Published online February 5, 2021)
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19. A Randomized Clinical Trial (JAMA. 2021;325(3):254-264. doi:10.1001/jama.2020.25864)
A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events (JAMA Published online February 5, 2021)
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants (JAMA Published online January 28, 2021)
Sorting Out Whether Vitamin D Deficiency Raises COVID-19 Risk (JAMA January 26, 2021 Volume 325, Number 4)
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021 (JAMA Published online February 12, 2021)
Emergence of a Novel SARS-CoV-2 Variant in Southern California (JAMA Published online February 11, 2021)
Outpatient Dietary Management of Electrolyte Disorders During COVID-19 (JAMA Internal Medicine Published online February 8, 2021)
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms (JAMA Network Open. 2021;4(1):e2035057. doi:10.1001/jamanetworkopen.2020.35057)
Food as medicine: A possible preventive measure against coronavirus disease (COVID-19) (Phytotherapy Research. 2020;34:3124–3136)
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection. The COVID A to Z Randomized Clinical Trial (JAMA Network Open. 2021;4(2):e210369. doi:10.1001/jamanetworkopen.2021.0369)
Estimation of US Children’s Educational Attainment and Years of Life Lost Associated With Primary School Closures During the Coronavirus Disease 2019 Pandemic (JAMA Network Open. 2020;3(11):e2028786. doi:10.1001/jamanetworkopen.2020.28786)
COVID-19 and mRNA Vaccines—First Large Test for a NewApproach (JAMA September 22/29, 2020 Volume 324, Number 12)
Relationships Between AcademicMedicine Leaders and Industry—Time for Another Look? (JAMA November 10, 2020 Volume 324, Number 18)
Therapy for Early COVID-19 A Critical Need (JAMA Published online November 11, 2020)
Risk of COVID-19 During Air Travel (JAMA November 3, 2020 Volume 324, Number 17)
COVID-19 Infection—Preventing Clinical Deterioration (JAMA Published online November 12, 2020)
COVID-19 of dialysis patients in Japan: current status and guidance on preventive measures
Coronavirus Disease 2019 (COVID-19) and Dialysis: The Experience in Singapore
Managing the COVID-19 pandemic: international comparisons in dialysis patients
Hemodialysis with Cohort Isolation to Prevent Secondary Transmission during a COVID-19 Outbreak in Korea
COVID-19 and the Kidney: From Epidemiology to Clinical Practice
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19). A Review
Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea
A brand-new cardiorenal syndrome in the COVID-19 setting
Kidney disease and electrolytes in COVID-19: more than meets the eye
Epidemiology of COVID-19 in an Urban Dialysis Center
Maintenance Hemodialysis and COVID-19: Saving Lives With Caution, Care, and Courage
Coronavirus disease 2019 in chronic kidney disease
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
The clinical characteristics of coronavirus-associated nephropathy
First considerations on the SARS‑CoV‑2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy
Presence of Genetic Variants Among Young Men With Severe COVID-19
Delivering Dialysis During the COVID-19 Outbreak: Strategies and Outcomes
Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID‑19 pandemic: survey of the Italian Society of Nephrology
Serosurveillance and the COVID-19 Epidemic in the US Undetected, Uncertain, and Out of Control
Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities
A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece
Review of the present features and the infection control challenges of COVID-19 pandemic in dialysis facilities
COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
The psychological impact of quarantine and how to reduce it: rapid review of the evidence
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health CareWorkers
Minimizing the risk of COVID-19 among patients on dialysis
COVID-19 Town Hall WEBINAR Registration Detail
Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19
PRESYMPTOMATIC TRASMISSION OF SARS- COV2
HD PTS WITH COVID-19
COVID experience in Lombardy, Italy
Management of kidney transplant immunosuppression LaPaz
ERA-EDTA sharing Milano experience on coronavirus management in dialysis centers
DIALYSIS COVID 2019 (Update)
Dialysis Facilities Brace for COVID-19 - Renal and Urology News
ERA-EDTA news and informations
CDC
2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China
Άρθρο NDT για την μείωση της διασποράς του COVID – 19 στην αιμοκάθαρση από το EUDIAL Working Group of ERA-EDTA
Watch the COVID-19 Organ Donation and Transplant Town Hall
WEBINAR «Infection Prevention and Control in the time of Covid-19».
Your invitation to the COVID-19 Town Hall Webinar